Read More

Verve Therapeutics Announced VERVE-101 Awarded Innovation Passport By UK MHRA For Treatment Of Heterozygous Familial Hypercholesterolemia

Verve Therapeutics, Inc. today announced that VERVE-101 has been awarded the Innovation Passport for the treatment of heterozygous familial hypercholesterolemia (HeFH) under the Innovative Licensing and Access Pathway (ILAP) by the Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory body of the United Kingdom (UK).

VERV

Read More

Resideo Announced Energy Integration With A. O. Smith

Resideo Technologies, Inc., a leading global provider of solutions for energy management, home comfort, security, and safety, today announced a partnership with A. O. Smith, one of the world's largest manufacturers of water heaters, to help customers reduce demand on the electric grid during peak times.

AOS